|
PNN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.901670E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.335500E-02 |
| Normal-vs-Stage2 |
5.055400E-01 |
| Normal-vs-Stage3 |
8.957800E-01 |
| Normal-vs-Stage4 |
7.712000E-01 |
| Stage1-vs-Stage2 |
6.085200E-01 |
| Stage1-vs-Stage3 |
3.654500E-02 |
| Stage1-vs-Stage4 |
4.795000E-01 |
| Stage2-vs-Stage3 |
4.580800E-01 |
| Stage2-vs-Stage4 |
7.601600E-01 |
| Stage3-vs-Stage4 |
7.046600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.864050E-02 |
| Normal-vs-AfricanAmerican |
1.462030E-01 |
| Normal-vs-Asian |
4.614600E-01 |
| Caucasian-vs-AfricanAmerican |
6.118800E-01 |
| Caucasian-vs-Asian |
7.918800E-01 |
| AfricanAmerican-vs-Asian |
9.249000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.144200E-02 |
| Normal-vs-Female |
3.701700E-02 |
| Male-vs-Female |
6.257600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.798800E-01 |
| Normal-vs-Extreme_Weight |
1.644160E-01 |
| Normal-vs-Obese |
2.496000E-02 |
| Normal-vs-Extreme_Obese |
3.331400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.817000E-01 |
| Normal_Weight-vs-Obese |
4.253200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.980800E-01 |
| Extreme_Weight-vs-Obese |
3.513000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.910600E-01 |
| Obese-vs-Extreme_Obese |
6.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.393500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.740000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.135800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.362400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.937000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.163800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.053530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.534200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.439900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.203150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.981600E-04 |
| Normal-VS-Type2 PRCC |
5.647800E-02 |
| Normal-VS-KIRP CIMP |
2.442200E-01 |
| Normal-VS-Unclassified PRCC |
2.574000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.19360102199562E-11 |
| Type1 PRCC-VS-KIRP CIMP |
9.546800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.615440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.133700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.183710E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.589400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.371000E-01 |
| Normal-vs-N1 |
3.576100E-02 |
| Normal-vs-N2 |
1.395190E-01 |
| N0-vs-N1 |
2.087600E-02 |
| N0-vs-N2 |
2.590400E-01 |
| N1-vs-N2 |
7.475700E-02 |
|
|
